Nuwiq for Women and Girls with Hemophilia A Needing Surgery

We are studying how well Nuwiq works to control bleeding during major surgery for women and girls with hemophilia A. The trial will also look at its safety and effects on blood product use.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Nuwiq
Nuwiq is a medicine that replaces missing clotting factor VIII to prevent and treat bleeding in people with hemophilia A.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Simoctocog Alfa
Simoctocog alfa is a substance that replaces missing clotting factor VIII to prevent and control bleeding in people with hemophilia A.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Vihuma

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
HUS Helsinki University Hospital
Coagulation Disorders Unit, Department of Hematology
Helsinki, Finland
Centre Hospitalier Regional Universitaire De Tours
Service : Hématologie - Hémostase
La Riche, France
Centre Hospitalier Universitaire De Nantes
Centre d'hémostase clinique - Laboratoire d'Hémostase
Nantes, France

Sponsor: Octapharma AG
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.